Anorexia and cachexia, asthenia, and lethargy (Q41121658)

27 September 2017

1 reference

title

Anorexia and cachexia, asthenia, and lethargy (English)

1 reference

27 September 2017

Watanabe S

1

1 reference

27 September 2017

Bruera E

series ordinal

2

1 reference

27 September 2017

publication date

1 February 1996

1 reference

Hematology / Oncology Clinics of North America

27 September 2017

published in

1 reference

27 September 2017

volume

10

1 reference

27 September 2017

issue

1

1 reference

27 September 2017

page(s)

189-206

1 reference

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Cachectin: more than a tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Clinical management of anorexia and cachexia in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Asthenia in patients with advanced cancer. Issues in symptom control. Part 1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Nutrition in cancer patients: an update and review of our experience. Issues in symptom control. Part 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Muscle Electrophysiology in Patients With Advanced Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Cognitive failure in patients with terminal cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Hydrazine sulfate in cancer patients with weight loss. A placebo-controlled clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

1 reference

7 January 2021

Modulation of tumor necrosis factor activities by a potential anticachexia compound, hydrazine sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Parental nutrition: is it oncologically logical?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Delirium in the elderly patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Body-composition changes in patients who gain weight while receiving megestrol acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Cancer-associated anorexia and cachexia. Implications for drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Corticosteroid therapy of preterminal gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Tumors secreting human TNF/cachectin induce cachexia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Efficacy of neuroleptics for hypoactive delirium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Depression as component of post-cranial irradiation somnolence syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

CNS Arousal Systems: Possible Role in Delirium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Effect of hydrazine sulfate on glucose-regulating enzymes in the normal and cancerous rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

A critique of instruments and methods to detect, diagnose, and rate delirium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

High-dose megestrol acetate. A possible treatment for cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Megestrol acetate in cancer anorexia and weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

1 reference

7 January 2021

Anorexins, asthenins, and cachectins in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Nutritional support in the cancer-bearing host. Effects on host and tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Hospice care: the treatment of pain in advanced cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

Oxpentifylline in endotoxaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970334-8

7 January 2021

10.1016/S0889-8588(05)70334-8

Identifiers

DOI

1 reference

27 September 2017

1 reference